Johns Hopkins spinout LifeSprout recently closed on $6.5 million in funding as it looks to bring soft tissue replacement technology to market, according to CEO Sashank Reddy.

The investment round was led by Medytox Investments, Kairos Ventures, Triskelion Capital and TEDCO.

Founded by Russell Martin, Hai-Quan Mao, Justin Sacks and Reddy, the company is developing a synthetic material that can be used to regrow soft tissue within the body. As we previously reported, the material provides space for the body to regenerate its own tissue over time. Down the road, the company believes it can be used to reconstruct parts of the body after trauma or disease, as we reported.

READ FULL ARTICLE HERE